The biologic market has grown expediently over the past few years, driven not only by the pandemic but also by the increasing demand for innovative …
Gilead lost several billion dollars in market value Wednesday after unnerving investors with updates about a key clinical trial of its most closely watched breast …
Innovent’s IBI101, is the first OX40-targeted molecule to receive IND approval in China Innovent Biologics, a world-class China-based biopharmaceutical company that develops and intends to …
U.S. FDA Grants Landmark Class II Approval for Clinical Grade Smartphone Testing – Healthy.io’s Dip.io Urinalysis Israel based Healthy.io, the first company in the world …
The company is awaiting for the results and expect them to further clarify an important part of their mission in integrating cannabinoid-based therapies into the …
U.S. regulators have placed a clinical hold on CRISPR Therapeutics’ lead candidate, spurring a double-digit drop in the Swiss biotech’s stock value by Thursday morning. …
